ABBV May 2020 100.000 put

OPR - OPR Delayed Price. Currency in USD
35.00
0.00 (0.00%)
As of 10:14AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close35.00
Open35.00
Bid23.30
Ask27.85
Strike100.00
Expire Date2020-05-15
Day's Range28.75 - 28.75
Contract RangeN/A
Volume10
Open Interest88
  • AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know
    Zacks

    AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know

    In the latest trading session, AbbVie (ABBV) closed at $75.27, marking a -0.61% move from the previous day.

  • Top Analyst Reports for Procter & Gamble, AbbVie & QUALCOMM
    Zacks

    Top Analyst Reports for Procter & Gamble, AbbVie & QUALCOMM

    Top Analyst Reports for Procter & Gamble, AbbVie & QUALCOMM

  • Agilysys, Manpower, Eli Lilly and Company, Innoviva and AbbVie highlighted as Zacks Bull and Bear of the Day
    Zacks

    Agilysys, Manpower, Eli Lilly and Company, Innoviva and AbbVie highlighted as Zacks Bull and Bear of the Day

    Agilysys, Manpower, Eli Lilly and Company, Innoviva and AbbVie highlighted as Zacks Bull and Bear of the Day

  • Signs of Coronavirus Slowdown Pep Up Wall Street: 5 Winners
    Zacks

    Signs of Coronavirus Slowdown Pep Up Wall Street: 5 Winners

    Wall Street continues to build on a steep rebound in the previous session after lockdown strategy stabilized coronavirus outbreak in the United States and abroad.

  • AbbVie Stock Rises 3%
    Investing.com

    AbbVie Stock Rises 3%

    Investing.com - AbbVie (NYSE:ABBV) Stock rose by 3.17% to trade at $78.04 by 09:58 (13:58 GMT) on Tuesday on the NYSE exchange.

  • A New Technical Strategy for AbbVie
    TheStreet.com

    A New Technical Strategy for AbbVie

    During Friday night's Mad Money program host Jim Cramer mentioned that there are some companies with confusing outlooks such as AbbVie Inc. , which acquired Allergan. Allergan's focus has been with Botox and cosmetic surgeries, which are also on hold. In the daily bar chart of ABBV, below, we can see that prices retreated to the August lows before rebounding in recent sessions.

  • Another Drug to Fight Coronavirus & 3 Picks
    Zacks

    Another Drug to Fight Coronavirus & 3 Picks

    Another drug is being tested to kill the virus (if we can figure out administration on humans).

  • Novo Nordisk's Rybelsus Gets EU Nod for Type II Diabetes
    Zacks

    Novo Nordisk's Rybelsus Gets EU Nod for Type II Diabetes

    Novo Nordisk (NVO) gains the EU approval for Rybelsus to address adult patients with insufficiently-controlled type II diabetes for improving glycemic control as an adjunct to diet and exercise.

  • Is AbbVie Stock A Buy As Coronavirus Worries Hammer The Market?
    Investor's Business Daily

    Is AbbVie Stock A Buy As Coronavirus Worries Hammer The Market?

    AbbVie stock initially fell on its $63 billion plan to buy Botox-maker Allergan, which helps the pharmaceutical company diversify as Humira patents expire. So, is ABBV stock a buy right now?

  • PR Newswire

    AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes

    AbbVie Inc. (NYSE: ABBV) ("AbbVie") announced today the extension of the expiration date of the offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes of certain series issued by Allergan Finance, LLC ("Allergan Finance"), Allergan, Inc. ("Allergan Inc"), Allergan Sales, LLC ("Allergan Sales") and Allergan Funding SCS ("Allergan Funding" and, together with Allergan Finance, Allergan Inc and Allergan Sales, "Allergan") (the "Allergan Notes") for new notes to be issued by AbbVie (the "AbbVie Notes") and the related consent solicitations (each, a "Consent Solicitation" and, collectively, the "Consent Solicitations") being made by AbbVie on behalf of Allergan to adopt certain amendments to each of the indentures (each, an "Allergan Indenture") governing the Allergan Notes. AbbVie hereby extends such expiration date from 5:00 p.m., New York City time, on April 10, 2020 to 5:00 p.m., New York City time, on April 24, 2020 (as the same may be further extended, the "Expiration Date").

  • With gowns and masks in short supply, researchers test drugs to prevent COVID-19 infections in health care workers
    MarketWatch

    With gowns and masks in short supply, researchers test drugs to prevent COVID-19 infections in health care workers

    At least three clinical trials for hydroxychloroquine are trying to establish whether the decades-old malaria medication can prevent COVID-19 infections in frontline health-care workers as hospitals across the country scramble to secure enough gowns and masks for their employees.

  • Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio
    Zacks

    Why AbbVie (ABBV) is a Top Dividend Stock for Your Portfolio

    Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.

  • AbbVie Stock Falls 3%
    Investing.com

    AbbVie Stock Falls 3%

    Investing.com - AbbVie (NYSE:ABBV) Stock fell by 3.10% to trade at $72.71 by 14:05 (18:05 GMT) on Friday on the NYSE exchange.

  • Jim Cramer Gives His Opinion On AbbVie, Domino's Pizza And More
    Benzinga

    Jim Cramer Gives His Opinion On AbbVie, Domino's Pizza And More

    Jim Cramer said on CNBC's "Mad Money Lightning Round" AbbVie Inc (NYSE: ABBV) traded lower on COVID-19, but he likes its dividend yield and it remains a great stock. It's a big position for his charitable trust fund.Clarivate Analytics PLC (NYSE: CCC) is a research company, but Cramer hadn't thought of it as a COVID-19 play. He needs to do more research to see if it is worth buying on that.Cramer is a buyer of Domino's Pizza, Inc. (NYSE: DPZ). He believes the company has a great delivery, which makes it a terrific investment.There is too much supply in the oil and gas pipelines sector, thinks Cramer. He doesn't like pipelines and natural gas anymore and he doesn't like Kinder Morgan Inc (NYSE: KMI).See more from Benzinga * RNC Genter Capital CEO Likes Tech, Health Care, Financials In Volatile Market(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • PR Newswire

    AbbVie to Host First-Quarter 2020 Earnings Conference Call

    AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will announce its first-quarter 2020 financial results on Friday, May 1, 2020, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie's Investor Relations website investors.abbvie.com. An archived edition of the session will be available later that day.